JDD Special Focus

Acne Case Reports

Stay up-to-date on new clinical findings on Acne. View the latest articles, case reports, editorial features, supplements, Podcast episodes and more!

 

Case Reports

Microneedling for Treatment of Acne Scars: Considerations on the Successful Management of This Aesthetic Procedure

Microneedling is a minimally invasive procedure for treating acne scars which has already been well-established, but it has been reborn in recent years because of innovative findings. It presents many advantages in comparison with other techniques more frequently used such as laser resurfacing and deep chemical peelings; in particular, it consents to achieve good or excellent results with a minimal time (2-3 days) of recovery and rare complications, even in dark phototypes.1,2 

Read Now

Sponsored

Featured Unlocked Article

Integrating Dermocosmetic Therapy for Acne: Addressing Severity Levels in Real-Life Experiences

Treating acne is not just about prescriptions—it is about pairing the right skincare routine with medical therapy. This JDD article highlights how combining pharmacological treatments with a personalized dermocosmetic regimen can improve results and keep patients on track.

Read Now

Derm Atlas

One of the key characteristics of acne is post-inflammatory hyperpigmentation and is most noticeable in darker skin tones. It is also important to point out that keloidal or hypertrophic scarring may result and should be considered when treating patients.

Here we can appreciate the erythema of inflammatory papules in lighter skin tones and the brown coloration of inflammatory papules mimicking post-inflammatory hyperpigmentation in darker skin tones.

Read Now

Podcast Episodes

State of Acne Management: Stud or Dud?

Do not pop, rather pick a therapeutic strategy from the wide array of new….oh wait, nevermind.  The world of acne treatment R&D is unfortunately shrinking as payors pick away at the medical necessity of managing the most common inflammatory skin disease. Like Marty McFly fading in that famous family photo, the spotlight on acne is shifting, enough to make Dr. Pimple Punisher Dr. Hilary Baldwin pick up a bottle of Prozac. But all hope is not lost.

Join JDD Podcast host Dr. Adam Friedman as he and Dr. Baldwin scour the therapeutic landscape and take a sharp left into the over the counter space to review accessible options to manage both the today and tomorrow of Acne Vulgaris, the symbiosis between RX and OTC to address barrier dysfunction, scarring and hyperpigmentation.

Listen Now

Sponsored

Dermatology News

Journal of Drugs in Dermatology JDD Article About An Exosome Regenerative Complex Plus Microneedling Promotes Hair Growth in Subjects With Self-Perceived Thinning HairFeatured ArticlesHairLatest NewsThe Latest
October 29, 2025

An Exosome Regenerative Complex Plus Microneedling Promotes Hair Growth in Subjects With Self-Perceived Thinning Hair

Exosome complex after microneedling shows promising hair‑regrowth signals in a 30‑patient series In a 30‑subject study (15 men, 15 women; mean age 50.2 years) treated with an Exosome Regenerative Complex+…
Journal of Drugs in Dermatology JDD Article About SAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing SkincareAtopic DermatitisFeatured ArticlesLatest NewsPediatricsThe Latest
October 28, 2025

SAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare

Think beyond inflammation: SAIGE framing reframes pediatric AD prevention and care A seven‑expert global panel of pediatric dermatologists and dermatologists used a modified Delphi process to produce five consensus statements…
Journal of Drugs in Dermatology JDD Article About Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 MonthsAtopic DermatitisFeatured ArticlesLatest NewsPediatricsThe Latest
October 27, 2025

Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months

Dupilumab delivers — but many patients need more than monotherapy over time In a US retrospective cohort (OM1 PremiOM™ AD) of 5,200 patients who started dupilumab between 2017-2021 (208 children, 430…
JDD HighlightsJDD WebinarsThe Latest
October 23, 2025

New Innovations of SkinCeuticals and Integrated Skincare

Join Dr. Kachiu Lee, a board-certified cosmetic dermatologist, to learn more about new innovations of SkinCeuticals. Dr. Lee will share the latest integrated skincare science from SkinCeuticals, focusing on products…